98 related articles for article (PubMed ID: 5737835)
1. [A strain of ascitic tumor NK-Ly, resistant to nitrosomethylurea].
Poroshenko GG; Gor'kova SN; Evseenko LS
Dokl Akad Nauk SSSR; 1968 Sep; 182(3):730-2. PubMed ID: 5737835
[No Abstract] [Full Text] [Related]
2. [The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
Krüger FW; Osswald H; Walker G; Schelten E
Z Krebsforsch; 1970; 74(4):434-47. PubMed ID: 4253315
[No Abstract] [Full Text] [Related]
3. Informal discussion: experimental basis for the chemical eradication of leukemia.
Frei E
Cancer Res; 1967 Dec; 27(12):2656-7. PubMed ID: 6082303
[No Abstract] [Full Text] [Related]
4. Criteria associated with destruction of leukemia and solid tumor cells in animals.
Skipper HE
Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
[No Abstract] [Full Text] [Related]
5. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
Cohen MH
J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
[No Abstract] [Full Text] [Related]
6. Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice.
Abraham D; Carbone PP; Venditti JM; Kline I; Goldin A
Biochem Pharmacol; 1967 Apr; 16(4):665-73. PubMed ID: 6033787
[No Abstract] [Full Text] [Related]
7. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
Ahmann DL; Hahn RG; Bisel HF
Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
[No Abstract] [Full Text] [Related]
8. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Kinne DW; Humphrey EW
Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
[No Abstract] [Full Text] [Related]
9. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
Olshin S; Siddiqui S; Firat D
Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
[No Abstract] [Full Text] [Related]
10. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
Carter SK; Newman JW
Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
[No Abstract] [Full Text] [Related]
11. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
Shapiro WR; Ausman JI; Rall DP
Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
[No Abstract] [Full Text] [Related]
12. [Marker chromosomes in the karyotype of cells of the NK-Ly ascitic tumor].
Poroshenko GG; Nikol'skaia TA
Dokl Akad Nauk SSSR; 1967 May; 174(1):210-2. PubMed ID: 5622446
[No Abstract] [Full Text] [Related]
13. Carcinogenesis and alkylation of rat liver nucleic acids by nitrosomethylurea and nitrosoethylurea administered by intraportal injection.
Lijinsky W; Garcia H; Keefer L; Loo J; Ross AE
Cancer Res; 1972 May; 32(5):893-7. PubMed ID: 5017739
[No Abstract] [Full Text] [Related]
14. [Significance of cellular kinetics in relation to chemotherapy of human leukemias].
Alberto P
Schweiz Med Wochenschr; 1971 Oct; 101(42):1510-5. PubMed ID: 5143015
[No Abstract] [Full Text] [Related]
15. [Effect of several antineoplastic compounds on the carbohydrate metabolism of transplanted tumors].
Chil-Akopian LA
Zh Eksp Klin Med; 1978; 18(2):49-54. PubMed ID: 685586
[No Abstract] [Full Text] [Related]
16. Design and evaluation of S-nitrosylated human serum albumin as a novel anticancer drug.
Katayama N; Nakajou K; Komori H; Uchida K; Yokoe J; Yasui N; Yamamoto H; Kai T; Sato M; Nakagawa T; Takeya M; Maruyama T; Otagiri M
J Pharmacol Exp Ther; 2008 Apr; 325(1):69-76. PubMed ID: 18218831
[TBL] [Abstract][Full Text] [Related]
17. The need for additional alkylating agents.
Connors TA
Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
[No Abstract] [Full Text] [Related]
18. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
Bonmassar E; Cudkowicz G; Vadlamudi S; Goldin A
Cancer Res; 1970 Oct; 30(10):2538-42. PubMed ID: 5474176
[No Abstract] [Full Text] [Related]
19. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Tyrer DD; Kline I; Venditti JM; Goldin A
Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
[No Abstract] [Full Text] [Related]
20. [Cross resistance studies in degranol resistant NK-ly ascites tumors].
Gáti E
Z Krebsforsch; 1966; 68(2):184-9. PubMed ID: 4228637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
